한글목차

집단검진 시장 규모는 2025년 355억 8,000만 달러에서 2026-2034년 CAGR 5.83%로 성장하여 2034년에는 592억 5,000만 달러에 달할 것으로 예측됩니다.

세계 집단검진 시장은 정부와 의료 기관이 질병의 조기 발견과 예방 의료에 초점을 맞추면서 꾸준히 성장하고 있습니다. 암, 당뇨병, 심혈관 질환 등 만성질환에 대한 인식이 높아지면서 대규모 검진 프로그램에 대한 수요가 증가하고 있습니다. 많은 국가들이 장기적인 의료비 절감과 생존율 향상을 목표로 국가 차원의 검진 정책에 투자하고 있습니다. 진단 도구와 디지털 헬스 시스템의 기술적 발전은 도시와 농촌 모두에서 보다 신속하고 정확한 검진 과정을 실현할 수 있도록 지원하고 있습니다.

주요 성장 요인 중 하나는 전 세계적으로 증가하는 생활습관병 및 유전성 질환의 부담입니다. 특히 선진국의 고령화는 정기적인 건강검진 프로그램에 대한 수요를 더욱 증가시키고 있습니다. 의료 서비스 접근성 개선, 보험 적용 범위 확대, 공중 보건 캠페인에 대한 정부 자금 투입이 시장을 강화하고 있습니다. 또한, AI와 데이터 분석을 검진 프로그램에 통합하여 위험 평가와 개인 맞춤형 의료를 개선하고, 검진의 효과와 신뢰성을 향상시키고 있습니다.

향후 몇 년 동안 재택 검진 키트와 모바일 헬스케어 유닛의 도입으로 시장은 더욱 확대될 것으로 예측됩니다. 신흥국에서는 헬스케어 인프라가 개선됨에 따라 강력한 성장 기회가 창출될 것으로 예측됩니다. 디지털 플랫폼과 원격 의료를 통해 원격지에 거주하는 사람들도 검진 서비스를 더 쉽게 이용할 수 있습니다. 예방 의료가 전 세계적으로 우선순위가 되는 가운데, 집단검진 시장은 지속적인 혁신과 장기적으로 지속 가능한 성장을 이룰 것입니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 집단검진 시장 : 제품별

제5장 세계의 집단검진 시장 : 비즈니스별

제6장 세계의 집단검진 시장 : 성별

제7장 세계의 집단검진 시장 : 유형별

제8장 세계의 집단검진 시장 : 연령별

제9장 세계의 집단검진 시장 : 지역별

제10장 경쟁 구도

제11장 기업 개요

영문목차

The Population Screening Market size is expected to reach USD 59.25 Billion in 2034 from USD 35.58 Billion (2025) growing at a CAGR of 5.83% during 2026-2034.

The Global Population Screening Market is growing steadily as governments and healthcare organizations focus more on early disease detection and preventive healthcare. Rising awareness about chronic diseases such as cancer, diabetes, and cardiovascular disorders is driving demand for large-scale screening programs. Many countries are investing in national screening initiatives to reduce long-term healthcare costs and improve survival rates. Technological advancements in diagnostic tools and digital health systems are also supporting faster and more accurate screening processes across urban and rural areas.

One of the main growth drivers is the increasing burden of lifestyle-related and genetic diseases worldwide. Aging populations, especially in developed countries, are further boosting the demand for regular health screening programs. Improved access to healthcare services, expansion of insurance coverage, and government funding for public health campaigns are strengthening the market. Additionally, the integration of AI and data analytics in screening programs is enhancing risk assessment and personalized care, making screening more effective and reliable.

In the coming years, the market is expected to expand further with the adoption of home-based screening kits and mobile health units. Emerging economies are likely to offer strong growth opportunities as healthcare infrastructure improves. Digital platforms and telemedicine will make screening services more accessible to remote populations. As preventive healthcare becomes a global priority, the population screening market is set to witness continuous innovation and long-term sustainable growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Business

• Hospitals
• Research Institutes
• Diagnostic Labs

By Gender

• Male
• Female

By Type

• Mass
• Premium

By Age

• Ages
• 15-65
• Ages 65+

COMPANIES PROFILED

• Agilent Technologies Inc, Thermo Fisher Scientific Inc, QIAGEN, F HoffmannLa Roche Ltd, Quest Diagnostics, Illumina Inc, ARUP Laboratories, Novogene Co Ltd, LGC Limited, Gene by Gene Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POPULATION SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POPULATION SCREENING MARKET: BY BUSINESS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Business
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POPULATION SCREENING MARKET: BY GENDER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Gender
• 6.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POPULATION SCREENING MARKET: BY TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Type
• 7.2. Mass Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Premium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL POPULATION SCREENING MARKET: BY AGE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Age
• 8.2. Ages
• 8.3. 15-65 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Ages 65+ Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL POPULATION SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Business
  • 9.2.3 By Gender
  • 9.2.4 By Type
  • 9.2.5 By Age
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Business
  • 9.3.3 By Gender
  • 9.3.4 By Type
  • 9.3.5 By Age
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Business
  • 9.4.3 By Gender
  • 9.4.4 By Type
  • 9.4.5 By Age
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Business
  • 9.5.3 By Gender
  • 9.5.4 By Type
  • 9.5.5 By Age
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Business
  • 9.6.3 By Gender
  • 9.6.4 By Type
  • 9.6.5 By Age
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL POPULATION SCREENING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Thermo Fisher Scientific Inc
  • 11.2.3 QIAGEN
  • 11.2.4 F. Hoffmann-La Roche Ltd
  • 11.2.5 Quest Diagnostics
  • 11.2.6 Illumina Inc
  • 11.2.7 ARUP Laboratories
  • 11.2.8 Novogene Co. Ltd
  • 11.2.9 LGC Limited
  • 11.2.10 Gene By Gene Ltd